Merck Tbk PT


Merck Tbk PT

Health CarePharmaceuticals and Biotechnology
  • Price (IDR)4,900.00
  • Today's Change70.00 / 1.45%
  • Shares traded65.40k
  • 1 Year change+29.63%
  • Beta1.2339
Data delayed at least 10 minutes, as of Feb 07 2023.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • MERK:JKT price moved over +1.04% to 4,880.00
  • MERK:JKT trading volume exceeds daily average by +21.24%
  • MERK:JKT price rises above 15-day moving average to 4,860.00 at 09:52 GMT
  • MERK:JKT price falls below 15-day moving average to 4,830.00 at 14:40 GMT
  • MERK:JKT price falls below 15-day moving average to 4,830.00 at 09:22 GMT

Key statistics

On Tuesday, Merck Tbk PT (MERK:JKT) closed at 4,900.00, -13.66% below its 52-week high of 5,675.00, set on Sep 14, 2022.
52-week range
3,700.00May 09 20225,675.00Sep 14 2022
Previous close4,900.00
Average volume33.07k
Shares outstanding448.00m
Free float59.81m
P/E (TTM)13.22
Market cap2.16tn IDR
EPS (TTM)365.22
Annual div (ADY)240.00
Annual div yield (ADY)4.97%
Div ex-dateJun 07 2022
Div pay-dateJun 24 2022
Data delayed at least 10 minutes, as of Feb 07 2023.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.